Auditing Vaccines

July 28th, 2017 - Paul Chandler
Categories:   Audits/Auditing   CPT® Coding  
0 Votes - Sign in to vote or comment.

Auditing vaccines can be difficult, as precise attention needs to be paid to the documentation to extract all variables needed for proper coding. Details such as age of the patient, format of administration, counseling performed, and quantity are all needed to properly code. Being familiar with those variables is needed to audit the chart and coding.

Vaccinations administered with counseling are coded with CPT© codes 90460 and 90461. Both codes require the patient to be through 18 years of age. Injections, intranasal, and oral forms of administration are covered with these codes. The first component is used with code 90460, with each additional component addressed with code 90461. Part of the difficulty in coding, and later in auditing, is being knowledgeable with the number of components per vaccine. Some are easy, such as code 90636 (Hepatitis A and hepatitis B vaccine (HepA-HepB), adult dosage, for intramuscular use) with two components. Others are more difficult to decipher. A good example is CPT code 90698: Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use. CPT code 90698 has five components. The proper administration when provided to a patient through 18 years of age, with counseling performed is: 90460, 90461 x 4.

Vaccinations administered without counseling to patients through 18 years of age have different coding options, based on the method of administration. Injections, whether it be percutaneous, intradermal, subcutaneous, or intramuscular are coded as 90471 for the first vaccine with 90472 used for each additional vaccine. Using the same example above, CPT 90698 would be coded with only one administration code, 90471, if the patient was through 18 years of age and no documentation of counseling being performed.

If the vaccine provided to the patient was given via intranasal or oral routes, with the patient being through 18 years of age with no documentation of counseling performed, the administration codes would be 90473 for the first vaccine, with 90474 for each additional vaccine.

Vaccine administration codes have a major impact on selection if the patient is through 18 years of age. The provider must document that he/she provided the patient counseling on the vaccines received. Depending on the coder and/or the office, the documentation may not support counseling was performed; however, the chart was coded with counseling because the physician may "always counsel her/his patients". The old phrase applies: if it is not documented, it did not happen.

For patients over 18 years of age the administration codes are more simplified. The physician does not get credit for counseling the patient in the code selection as codes 90460- 90461 would not apply. CPT codes 90471-90472 are used for the administration of vaccines performed by injection. CPT codes 90473-90474 are used for the administration of vaccines performed by intranasal or oral routes. Both code range sets apply per vaccine, not per component of the vaccine.

In auditing vaccines, the main focus is to be knowledgeable on the number of components per vaccine. With that information to audit, along with the understanding of the administration codes based on age, counseling, and route of administration, the auditor will be able to successfully ensure proper coding rules were followed for proper reimbursement.

###

Questions, comments?

If you have questions or comments about this article please contact us.  Comments that provide additional related information may be added here by our Editors.


Latest articles:  (any category)

Where is the CCI Edit with Modifier 25 on E/M?
May 20th, 2020 - Christine Woolstenhulme, QCC, CMCS, CPC, CMRS
If you are not seeing a CCI edit when reporting an E/M code with a certain procedure, it may be that there is no edit. CMS does not have a CCI edit for every CPT code, however, there are still general coding rules that must be followed.  The use of Modifier 25 is one example ...
Packaging and Units for Billing Drugs
May 18th, 2020 - Christine Woolstenhulme, QCC, CMCS, CPC, CMRS
To determine the dosage, size, doses per package and how many billing units are in each package, refer to the NDC number. Take a look at the following J1071 - Injection, testosterone cypionate, 1mg For example; using NCD # 0009-0085-10 there are 10 doses of 100 mL (100 mg/mL = 1 mL and there are ...
Getting Your Practice Back on Track
May 12th, 2020 - Wyn Staheli, Director of Research
As we begin returning back to work, we will all face a new normal. The COVID-19 pandemic has changed the face of business. While it has certainly been a challenge to keep up with the ever-changing regulations (that’s likely to continue for a little longer), exciting new opportunities have also been created, such as the expansion of telemedicine. There’s also the maze of government funding that needs to be navigated and an increased awareness of OSHA standards to implement.
ICD-10-CM - Supplement information for E-Cigarette/Vaping Reporting
May 5th, 2020 - Christine Woolstenhulme, QCC, CMCS, CPC, CMRS
The CDC has released additional information and coding guidance for reporting encounters related to the 2019 health care encounters and deaths related to e-cigarette, or vaping, product use associated lung injury (EVALI).  The update offers coding scenarios for general guidance, poisoning and toxicity, substance abuse and signs and symptoms.  ICD-10-CM Official Coding Guidelines - ...
Additional Telehealth Changes Announced by CMS
May 4th, 2020 - Wyn Staheli, Director of Research
On April 30, 2020, CMS announced additional sweeping changes to meet the challenges of providing adequate healthcare during this pandemic. These changes expand the March 31st changes. The article covers some of the key changes. See the official announcement in the references below.
Effective Risk Adjustment Requires Accurate Calculations
April 27th, 2020 - Wyn Staheli, Director of Research
Risk adjustment is simply a way of making sure that there are sufficient funds to adequately take care of the healthcare needs of a certain population. It’s a predictive modeling methodology based on the diagnoses of the individuals in that population. As payers move to value based models, they heavily rely on risk adjustment to ensure proper funding.
COVID-19 Clinical Trial Participation Helps Providers Earn MIPS Credit
April 22nd, 2020 - Wyn Staheli, Director of Research
All healthcare providers who are currently participating in the MIPS portion of Medicare’s Quality Payment Program may want to participate in the new COVID-19 Clinical Trials improvement activity. Read more about it here.



Home About Contact Terms Privacy

innoviHealth® - 62 E 300 North, Spanish Fork, UT 84660 - Phone 801-770-4203 (9-5 Mountain)

Copyright © 2000-2020 innoviHealth Systems®, Inc. - CPT® copyright American Medical Association